| scholarly article | Q13442814 |
| P50 | author | Philip Scheltens | Q22280357 |
| Connie Jimenez | Q56887123 | ||
| Charlotte Teunissen | Q56887227 | ||
| Marta Del Campo Milan | Q85840992 | ||
| P2093 | author name string | Leah Zuroff | |
| P2860 | cites work | Alzheimer Disease in the US Population | Q22253055 |
| Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain | Q22253180 | ||
| A two disulfide bridge Kazal domain from Phytophthora exhibits stable inhibitory activity against serine proteases of the subtilisin family | Q24816498 | ||
| Agrin in the developing CNS: new roles for a synapse organizer | Q28203484 | ||
| Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma | Q28645584 | ||
| Alzheimer's disease | Q29616743 | ||
| A novel disulfide pattern in laminin-type epidermal growth factor-like (LE) modules of laminin β1 and γ1 chains | Q30318595 | ||
| On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics | Q33518240 | ||
| Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity | Q34554590 | ||
| Agrin in the CNS: a protein in search of a function? | Q34828047 | ||
| CSF markers for incipient Alzheimer's disease | Q35541472 | ||
| Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice | Q35571874 | ||
| Age and diagnostic performance of Alzheimer disease CSF biomarkers. | Q35758640 | ||
| Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. | Q35787956 | ||
| Transmembrane agrin regulates dendritic filopodia and synapse formation in mature hippocampal neuron cultures | Q37308567 | ||
| Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting | Q38465617 | ||
| The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis | Q40759751 | ||
| CSF biomarker levels in early and late onset Alzheimer's disease | Q46652052 | ||
| Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals | Q46814740 | ||
| Synapse loss in cortex of agrin-deficient mice after genetic rescue of perinatal death. | Q48115828 | ||
| CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study | Q48381623 | ||
| CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease | Q48408159 | ||
| Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques | Q48606558 | ||
| Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity | Q48983820 | ||
| Optimizing patient care and research: the Amsterdam Dementia Cohort. | Q50712172 | ||
| Clinical validity of Braak neuropathological staging in the oldest-old | Q53234837 | ||
| Agrin and microvascular damage in Alzheimer’s disease | Q60145604 | ||
| Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease | Q72119373 | ||
| P433 | issue | 1 | |
| P921 | main subject | biomarker | Q864574 |
| Alzheimer's disease | Q11081 | ||
| cerebrospinal fluid | Q54196 | ||
| P304 | page(s) | 75-80 | |
| P577 | publication date | 2015-03-29 | |
| P1433 | published in | Alzheimer's & dementia (Amsterdam, Netherlands) | Q27726390 |
| P1476 | title | Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease? | |
| P478 | volume | 1 |
Search more.